UA23383A - Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis - Google Patents

Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis

Info

Publication number
UA23383A
UA23383A UA95031406A UA95031406A UA23383A UA 23383 A UA23383 A UA 23383A UA 95031406 A UA95031406 A UA 95031406A UA 95031406 A UA95031406 A UA 95031406A UA 23383 A UA23383 A UA 23383A
Authority
UA
Ukraine
Prior art keywords
patients
renal insufficiency
anemia treatment
terminal renal
under hemodialysis
Prior art date
Application number
UA95031406A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петро Степанович Серняк
Петр Степанович Серняк
Ігор Анатолійович Деркач
Игорь Анатолиевич Деркач
Віктор Костянтинович Денісов
Виктор Константинович Денисов
Вадим Васильович Захаров
Вадим Васильевич Захаров
Таміла Іванівна Клинчук
Тамила Ивановна Клинчук
Аслан Авірхановіч Кубатієв
Аслан Авирханович Кубатиев
Сергій Григорович Фролов
Сергей Григорьевич Фролов
Іван Юрійович Антоневич
Иван Юрьевич Антоневич
Original Assignee
Донецький державний медичний університет ім.Горького
Донецкий государственный медицинский университет им.Горького
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донецький державний медичний університет ім.Горького, Донецкий государственный медицинский университет им.Горького filed Critical Донецький державний медичний університет ім.Горького
Priority to UA95031406A priority Critical patent/UA23383A/en
Publication of UA23383A publication Critical patent/UA23383A/en

Links

Abstract

The invention relates to medicine. An anemia treatment is carried out by hemostimulating drug administration. The previously irradiated by a dose of 9-31 Gray autoblood is additionally intravenously administered to a patient in quantity 4-5 % of circulatory blood volume with the interval of 75-90 days.
UA95031406A 1995-03-29 1995-03-29 Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis UA23383A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA95031406A UA23383A (en) 1995-03-29 1995-03-29 Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA95031406A UA23383A (en) 1995-03-29 1995-03-29 Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis

Publications (1)

Publication Number Publication Date
UA23383A true UA23383A (en) 1998-08-31

Family

ID=74315109

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95031406A UA23383A (en) 1995-03-29 1995-03-29 Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis

Country Status (1)

Country Link
UA (1) UA23383A (en)

Similar Documents

Publication Publication Date Title
SG48701A1 (en) Apparatus and method for preventing hypotension in a dialysis patient
Bennett A multicenter clinical trial of epoetin beta for anemia of end-stage renal disease.
TW200301694A (en) Bicarbonate-based solutions for dialysis therapies
HUT43948A (en) Emulsion compositions for dosing ionizable hydrophobic medical substances which are little soluble in water and process for preparing the same
DE69230112D1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
IE790951L (en) Carnitine solution
Roubin et al. Intravenous nitroglycerine in refractory unstable angina pectoris
Kaupke et al. Effect of recombinant human erythropoietin on platelet production in dialysis patients.
EP0869788B1 (en) Compositions for the treatment of renal failure, comprising l-carnosine
EA199900609A1 (en) METHOD AND PHARMACEUTICAL COMPOSITION FOR DELIVERY OF IRON IN PATIENTS RECEIVING HEMODIALYSIS AND PERITONEAL DIALYSIS
UA23383A (en) Method for anemia treatment in patients with terminal renal insufficiency, which are under hemodialysis
Canaud et al. Erythropoietin-associated hypertension: what role for blood viscosity changes?
Nolph et al. Problems in comparisons of clearances prescriptions in hemodialysis and continuous ambulatory peritoneal dialysis
US4552865A (en) Psychotropic drugs
SU1507380A1 (en) Method of treatment of hearing disorders
RU2016580C1 (en) Method of curing complicated rheumatoid arthritis
SU722544A1 (en) Hemodialysis method
RU2233657C2 (en) Method for treatment of lichen ruber planus
RU2132188C1 (en) Method of treating thyroid gland hypofunction
SU1573426A1 (en) Method of treatment of destructive tuberculosis of the lungs
SU1724272A1 (en) Method for treatment of patients with pyoperitonitis
UA30251A (en) The method for treatment of oddis sphincter hypertonia for patients with chronic acalculous cholecystitis along with hypersympathicotonia
RU1821211C (en) Hypolipidemic medicine
Hooley et al. Dental management of patients with renal failure being treated by hemodialysis